TY - JOUR
T1 - MRI-guided definition of cerebrospinal fluid distribution around cranial and sacral nerves
T2 - implications for brain tumors and craniospinal irradiation
AU - Wood, Amber M.
AU - Lequin, Maarten H.
AU - Philippens, Marielle M.
AU - Seravalli, Enrica
AU - Plasschaert, Sabine L.
AU - van den Heuvel-Eibrink, Marry M.
AU - Janssens, Geert O.
N1 - Publisher Copyright:
© 2019, © 2019 Acta Oncologica Foundation.
PY - 2019/12/2
Y1 - 2019/12/2
N2 - Background: The SIOPE-Brain Tumor Group recently published a guideline on craniospinal target volume delineation for highly conformal radiotherapy. In order to spare critical structures like e.g., the lens or cochlea, highly conformal techniques can underdose the cerebrospinal fluid (CSF) in the dural reflections around cranial and sacral nerves. The purpose of this study is to generate evidence for CSF extension within the dural sheaths of the cranial and sacral nerves in order to improve accuracy in target volume delineation. Material and methods: Ten healthy volunteers, age 21 till 41 years, underwent an MRI-scan of the skull-base and sacral plexus. To evaluate CSF extension, cT2-weighted images with fat suppression, low signal to noise ratio and little to no motion-related artifacts were used. Two observers measured the extension of CSF from the inner table of the skull for the cranial nerves, and outside the spinal canal for the sacral nerves. Results: CSF extension (mean distance [95% CI]) was visible within the dural sheaths surrounding the majority of the cranial nerves: optic nerve (40 mm [38–42]), trigeminal nerve (16 mm [15–19]), facial-vestibulocochlear nerve (11 mm [11–12]), glossopharyngeal-vagus-accessory nerve (7 mm [7–9]) and hypoglossal nerve (8 mm [7–9]). No CSF was observed outside the spinal canal at sacral level. No significant difference between both observers was measured. Conclusion: This study generates evidence for significant CSF extension outside the inner table of the skull. Despite the vicinity of the lens and cochlea, we therefore recommend the inclusion of both optic nerves and internal auditory canals in the clinical target volume for craniospinal irradiation when using highly conformal delivery techniques.
AB - Background: The SIOPE-Brain Tumor Group recently published a guideline on craniospinal target volume delineation for highly conformal radiotherapy. In order to spare critical structures like e.g., the lens or cochlea, highly conformal techniques can underdose the cerebrospinal fluid (CSF) in the dural reflections around cranial and sacral nerves. The purpose of this study is to generate evidence for CSF extension within the dural sheaths of the cranial and sacral nerves in order to improve accuracy in target volume delineation. Material and methods: Ten healthy volunteers, age 21 till 41 years, underwent an MRI-scan of the skull-base and sacral plexus. To evaluate CSF extension, cT2-weighted images with fat suppression, low signal to noise ratio and little to no motion-related artifacts were used. Two observers measured the extension of CSF from the inner table of the skull for the cranial nerves, and outside the spinal canal for the sacral nerves. Results: CSF extension (mean distance [95% CI]) was visible within the dural sheaths surrounding the majority of the cranial nerves: optic nerve (40 mm [38–42]), trigeminal nerve (16 mm [15–19]), facial-vestibulocochlear nerve (11 mm [11–12]), glossopharyngeal-vagus-accessory nerve (7 mm [7–9]) and hypoglossal nerve (8 mm [7–9]). No CSF was observed outside the spinal canal at sacral level. No significant difference between both observers was measured. Conclusion: This study generates evidence for significant CSF extension outside the inner table of the skull. Despite the vicinity of the lens and cochlea, we therefore recommend the inclusion of both optic nerves and internal auditory canals in the clinical target volume for craniospinal irradiation when using highly conformal delivery techniques.
UR - http://www.scopus.com/inward/record.url?scp=85073986227&partnerID=8YFLogxK
U2 - 10.1080/0284186X.2019.1667023
DO - 10.1080/0284186X.2019.1667023
M3 - Article
C2 - 31526171
AN - SCOPUS:85073986227
SN - 0284-186X
VL - 58
SP - 1740
EP - 1744
JO - Acta Oncologica
JF - Acta Oncologica
IS - 12
ER -